Author name: Nilotpal Chakravarti

Product, growth and commercial decisions are increasingly carrying regulatory consequences. Recent e-commerce rules and enforcement show why businesses may need to spot the policy question before a product decision is already made.

Regulatory uncertainty does not stop business decisions. The real question is whether companies understand the regulatory assumptions those decisions are built on.

Most strategic discussions begin with the most visible issue in the room. A new regulation, a competitor’s move, a changing market or a customer problem quickly becomes the centre of the conversation. Yet, in focusing on the trigger, leadership teams often overlook a more fundamental question: what decision is the business actually trying to make? That single question can change the quality of every discussion that follows.

Many regulatory surprises occur not because companies fail to read the law, but because they underestimate how institutions view risk. As technology reshapes industries, understanding how institutions think may become as important as understanding markets and customers.

India’s regulatory evolution is increasingly moving beyond licences, disclosures, and periodic compliance checks. Across sectors, infrastructure itself is beginning to create visibility, traceability, and accountability at scale. This piece explores how governance is gradually shifting from episodic oversight to systems where regulation becomes embedded into architecture itself.

Most organisations assume regulatory risk begins when a rule is violated. In reality, friction often starts much earlier — in the gap between what a company believes is compliant and what the system is willing to accept. This piece explores how interpretation, institutional judgment, and evolving regulatory priorities shape outcomes across sectors.

Most healthtech companies don’t run into trouble by ignoring regulation. They run into trouble by believing they are compliant, until the regulatory lens shifts and exposes the gap.

Over the years, I’ve seen companies misread regulatory risk not because they are careless, but because they often seek certainty from the wrong signals. This piece examines why that happens.